Second NJ-Based Pharmaceutical Company Admits to Price Fixing,

NJ 2019 Independent Pharmacies

DOJ False Claims Act Anti Kickback Conspiracy

Penalty

$3.6 million

Outcome

Second NJ-Based Pharmaceutical Company Admits to Price Fixing, Resolves Related False Claims Act Violations

Details

Second NJ-Based Pharmaceutical Company Admits to Price Fixing, — DOJ Enforcement (2019)

Outcome: Second NJ-Based Pharmaceutical Company Admits to Price Fixing, Resolves Related False Claims Act Violations

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.

Source: DOJ Press Release — Second NJ-Based Pharmaceutical Company Admits to Price Fixing, Resolves Related False Claims Act Violations

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works